RxDoctor Payments Data

Kenneth Pruett

Psychiatric/Mental Health · Blytheville, ARNPI 1952524878

Payments from drug & device makers

$498in general payments, 2019–2025

Across 27 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$109
  • Alkermes, Inc.$86
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$72
  • Sunovion Pharmaceuticals Inc.$55
  • AbbVie$39
  • E.r. Squibb & Sons, L.L.C.$35
  • plus $102 from 4 others

What the payments were for

  • Food & beverage$45191%
  • Education$479%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$498 in reported general payments places this provider in the 40th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$20,181
Medicare patients
73
Services billed
226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate86$269,497
RexultiBrexpiprazole31$45,655
VraylarCariprazine Hcl23$32,301
Risperdal ConstaRisperidone Microspheres14$21,510
Aripiprazole265$10,158
TrintellixVortioxetine Hydrobromide12$5,937
Quetiapine Fumarate ErQuetiapine Fumarate29$4,762
Paliperidone ErPaliperidone39$4,407
Atomoxetine Hcl22$3,528
Clonazepam343$3,080
Buspirone Hcl289$3,080
Quetiapine Fumarate254$2,797
Divalproex Sodium ErDivalproex Sodium44$2,341
Ziprasidone Hcl51$2,062
Lurasidone Hcl71$1,989

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$109$45,65531 claims
AbbVieVraylar$39$32,30123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Blytheville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →